New York University
274
49
72
147
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.9%
19 terminated/withdrawn out of 274 trials
88.6%
+2.0% vs industry average
5%
15 trials in Phase 3/4
39%
57 of 147 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (274)
Chinese American Cancer Survivors Writing Study
Role: lead
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
Role: collaborator
Supporting Sustained HIV Treatment Adherence After Initiation
Role: collaborator
Effects of Racial Congruence, "Likes", and Food Images in Social Media Ads on Adolescents' Caloric Intake - Study 3
Role: collaborator
WeCare: A System of Care for Black Youth
Role: lead
Evaluating Smoking Cessation Interventions for PWH in South Africa
Role: collaborator
Streamlined Treatment and Evidence-based Adolescent Counseling and Medication Support (STREAMS)
Role: collaborator
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Role: collaborator
Hirschsprung Disease Genetic Study
Role: collaborator
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Role: lead
Community-based Education, Navigation, and Support Intervention for Military Veterans
Role: lead
Baby's First Years
Role: collaborator
Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect
Role: lead
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
Role: lead
Psorcast Mobile Study
Role: collaborator
A Randomized Control Trial of Motor-based Intervention for CAS
Role: lead
Implementing Tobacco Use Treatment in HIV Clinics Vietnam
Role: lead
Voice Therapy Per the Rehabilitation Treatment Specification System
Role: collaborator
TREAT to Improve Cardiometabolic Health
Role: collaborator
WOOP VA: Promoting Weight Management in Primary Care
Role: collaborator